Join the live conversation with Dr. Etkin-Kramer and Kristie as they discuss the overwhelming evidence that supports the importance of a patient ‘knowing their risk’. Obstetrician–gynecologists play a vital role in identifying and managing women at risk for hereditary cancer syndromes. Identification of high-risk women is vital to implement education, testing, personalized cancer early-detection and risk reduction measures to improve health and quality of life.
Dr. Etkin-Kramer will discuss how she effectively implements a successful screening protocol and testing strategy into her clinical workflow. You will learn about Sema4’s evidence-based hereditary cancer testing solutions, genetic counseling support, and digital tools that can easily be integrated into your practice. Stay tuned until the end for a Q&A with the panelists.
|Recorded On||December 1, 2020, 7-8pm ET|
Elizabeth Etkin-Kramer, M.D.
Founder of Yodeah
Associate Professor in OBGYN at FIU Herbert Wertheim College of Medicine
Kristie N. Smith, MS, CGC,
Sr Director, Clinical Support, Education & Training, Sema4